Bal Pharma Ltd Q2 FY27 Unaudited Financial Results Filed

Bal Pharma Ltd has filed its unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The Board of Directors approved these results. The company also confirmed that there has been no deviation in the utilization of proceeds from its preferential issue of warrants. A limited review report from the statutory auditors has been submitted, indicating no material misstatements in the interim financial statements. The company also declared no outstanding defaults on loans and debt securities.